In addition, the combination of luteolin and cisplatin (178) not only significantly inhibited cell migration and invasion, but also promoted early apoptosis of cancer cells by down-regulating Bcl-2, and enhanced the anti-proliferative effect of cisplatin on ovarian cancer CAOV3/DDP cells. This evidence concerns the gene BCL2 and cancer.